Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$463.46/sh−2,724$1,262,465→ 74,722 total
Holdings
- 140(indirect: By 401(k))
Common Stock